Navigation Links
Surveyed Endocrinologists Consider Eli Lilly's Dulaglutide To Have an Edge Over Competitors for the Treatment of Type 2 Diabetes Patients Who Are Inadequately Controlled On Metformin
Date:11/26/2013

BURLINGTON, Mass., Nov. 26, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, among a range of current and emerging therapies, surveyed endocrinologists in the United States and Europe indicate that Eli Lilly's novel glucagon-like peptide 1 (GLP-1) receptor agonist dulaglutide has the optimal balance of efficacy, safety and tolerability, and delivery attributes for the treatment of patients with type 2 diabetes who are inadequately controlled with metformin. In the crowded type 2 diabetes second-line treatment landscape, dulaglutide's delivery attributes give it a slight edge over other currently available and emerging therapies, which include agents from the following drug classes: GLP-1 receptor agonists, dipeptidyl peptidase-IV inhibitors and sodium glucose cotransporter 2 inhibitors.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO )

The 2013 DecisionBase report entitled Type 2 Diabetes: When Metformin Has Lost the Battle for Glycemic Control, What Antidiabetic Agents Win Endocrinologists' Backing? also finds that surveyed endocrinologists are most compelled by drugs that reduce glycated hemoglobin A1c (HbA1c) levels. However, the high price of novel type 2 diabetes agents could offset endocrinologists' receptivity to such agents. Payers also indicate that they would only accommodate high price premiums in the presence of substantial improvements in efficacy. In addition, U.S. and European endocrinologists regard reductions in bodyweight as an important unmet need, reflecting the high prevalence of excess weight in the type 2 diabetes population.

The findings also reveal that surveyed end
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Two-Thirds of Surveyed U.S. Neurologists Have Prescribed Genzymes Aubagio to Their Multiple Sclerosis Patients at One Year Post-Launch
2. Surveyed EU5 Rheumatologists Prescribe Biologics to Approximately Half of Their DMARD-Treated Psoriatic Arthritis Patients
3. Surveyed EU5 Oncologists Plan Increased Uptake of Perjeta for HER2-Positive Breast Cancer, But Expect Reimbursement Hurdles for Perjeta Plus Kadcycla
4. Surveyed Physicians Report that Invokana Captures a Small Percentage of Patient Share in the Type 2 Diabetes Drug Market, With Significant Increases Expected Six Months from Now
5. Surveyed U.S. Rheumatologists are Moderately Satisfied with Biologic Agents and Xeljanz to Treat Rheumatoid Arthritis
6. More than a Third of Chronic Kidney Disease-Non-Dialysis Patients are Likely Candidates for FG-4592/ASP1517, According to Surveyed EU5 Nephrologists
7. At One Month Post-Launch, Nearly a Quarter of Surveyed U.S. Oncologists Have Prescribed Tafinlar for Malignant Melanoma, Compared to 15 Percent Who Used Mekinist
8. Should Mircera Reach the U.S. Market, Surveyed Nephrologists State that at Least 40 Percent of CKD-ND and Dialysis Patients are Likely Candidates
9. According to Surveyed U.S. Oncologists, Zytiga is the Patient-Share Leader in First-Line Metastatic Castrate-Resistant Prostate Cancer
10. Surveyed U.S. Neurologists Report Greater Overall Satisfaction with Tecfidera than with Platform Injectables and Other Oral Multiple Sclerosis Therapies
11. At One Month Post-Launch, Nearly One-Quarter of Surveyed U.S. Medical Oncologists Have Prescribed Xofigo to Their Prostate Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ALISO VIEJO, Calif. , Sept. 3, ... a leading global pharmaceutical company, and AqueSys, Inc. ... on developing ocular implants that reduce intraocular pressure ... have entered into an agreement under which Allergan ... the terms of the agreement, Allergan will acquire ...
(Date:9/3/2015)... Research and Markets ... the "Investigation Report on China,s Progesterone Market, ... The clinical demand for steroid drug is increasing ... efficacy especially its extended use in regulating human ... Progesterone, a natural progestogen produced by the ...
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... the addition of the "Investigation Report on China,s ... Developed by Genentech, trastuzumab was approved by FDA ... under the trade name of Herceptin, a major product ... was USD 6.56 billion around the world. After ...
Breaking Medicine Technology:Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6China Progesterone Market Investigation Report 2015-2019 2Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2
... (Nasdaq: CDXS ) today announced the company will ... 2010 at 4:30 p.m. Eastern Time to discuss its third ...  The call and webcast will follow the release of third ... the call will be available approximately one hour after the ...
... Today the Roskamp Institute said that it is pleased ... RCP-006, a compound found in tobacco, for the treatment of ... a subsidiary of Star Scientific in Virginia, and made available ... In laboratory tests with cells, the compound, RCP-006, a ...
Cached Medicine Technology:Roskamp Institute to Begin Human Alzheimer's Clinical Trials With a Natural Compound in Tobacco 2
(Date:9/3/2015)... ... ... TransPack Toon gives users a set of 90 cartoon transitions for ... 30 different styles. Presets range from snow, underwater, forest, futuristic, city and many more. ... 90 cartoon transitions from 30 unique styles. Editors can choose between line and ...
(Date:9/3/2015)... ... September 03, 2015 , ... E-Volve Health, an Elliot ... healthcare solutions organization, to provide electronic medical record (EMR) consulting services to Amerinet ... will receive negotiated pricing on E-Volve Health’s Epic EMR consulting, custom training and ...
(Date:9/3/2015)... ... 03, 2015 , ... DriButts, a non-profit organization dedicated to ... Development Group to manufacture a long-lasting reusable diaper for warm weather climates where ... bring 600 DriButts Diapers to rural areas of Haiti during a trip scheduled ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... care community to be situated at 4400 Columbine Drive in Bellingham, Washington. Silverado ... 2016, and has been carefully designed to serve up to 80 people living ...
(Date:9/3/2015)... San Jose, CA (PRWEB) , ... September 03, ... ... high-performance Splashtop remote desktop solution for LANDESK Management Suite customers, as part of ... Management Suite’s user-centered approach to IT, by delivering the best mobile user experience ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4
... just 3 to 5 hours sleep per night, study shows, , , ... teens is getting the recommended eight hours of sleep each night. ... help of highly-caffeinated energy drinks, according to new research. , ... teens polled reported falling asleep in school at least twice ...
... Chemical-Free Cleaning Process Offers Greater than 99.9 Percent Bacterial ... Pro, a convenient hand-held device that offers a breakthrough ... powerful general-purpose cleaner, has now been certified as a ... as directed, the Activeion Pro offers a greater than ...
... a considerable and largely undetected problemSAN FRANCISCO, May ... are away from work significantly longer than other ... by the non-profit Integrated Benefits Institute. The true ... payments and lost productivity -- are 2-1/2 times ...
... Holdings, Inc. (Pink Sheets: NXGH) is pleased to ... Billion Household and Industrial Cleaning Products Industry by ... a company which manufactures and distributes non-toxic, environmentally ... Green Bridge Industries in exchange for a combination ...
... --Data from Ongoing Glioblastoma Dosimetry Trial Accepted for ... Annual Meeting ----Over 65 Recurrent GBM Patients in ... Received Cotara to Date, with a Good Safety ... Calif., May 28 Peregrine Pharmaceuticals, Inc. (Nasdaq: ...
... of Tart Cherries May Help Relieve Post-Exercise Muscle Pain ... ease the pain for people who run, according to ... at the American College of Sports Medicine Conference in ... cherry juice while training for a long distance run ...
Cached Medicine News:Health News:Technology, Caffeine Keeping Teens Awake 2Health News:Technology, Caffeine Keeping Teens Awake 3Health News:Certified Lab Tests Confirm the Activeion Pro Is a Sanitizing Device 2Health News:Certified Lab Tests Confirm the Activeion Pro Is a Sanitizing Device 3Health News:IBI Research Finds Employers Severely Underestimate the Prevalence and Lost Productivity Costs of Depression 2Health News:IBI Research Finds Employers Severely Underestimate the Prevalence and Lost Productivity Costs of Depression 3Health News:NXGen Holdings, Inc. Enters the $17.5 Billion Household and Industrial Cleaning Products Industry through the Acquisition of Green Bridge Industries, Inc. 2Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 2Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 3Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 4Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 5Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 6Health News:Is Cherry Juice a New 'Sports Drink?' 2
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Stryker autoclavable pediatric laparoscopes provide equivalent brightness and resolution along with the unparalleled durability found in larger laparoscopes....
Inquire...
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Medicine Products: